spacer
home > pmps > winter 2003 > reinventing biopharmaceutical manufacturing with single-use disposable systems
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Reinventing Biopharmaceutical Manufacturing with Single-Use Disposable Systems

Advancements in biotechnology and bioprocessing are driving the rapid development, commercialisation and availability of biopharmaceuticals globally. The US Department of Commerce reported in 2003 that there were more than 370 biotech drugs and vaccines in clinical trials in the US. Additionally, of the 155 biotechnology drugs and vaccines that have received regulatory approval from the Food and Drug Administration (FDA) to date, 70 per cent of these have been in the last six years (1).

Technological breakthroughs have resulted in an unprecedented number of drugs and biologics currently in research and development phases. Biopharmaceutical manufacturers face increased pressure to commercialise new and unique therapies faster and at lower cost. As a result, production demand is outpacing available manufacturing capacity. To meet existing and future demand and maintain a competitive advantage, many manufacturers are striving to develop increased efficiencies within their manufacturing processes.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Carolyn Franceschi, Medical Business Unit Manager at Colder Products Company

Carolyn Franceschi is Business Unit Manager for Medical Products at Colder Products Company. Carolyn is a member of the Biomedical Engineering Institute at the University of Minnesota, MNBIO, and Medical Alley. She holds a BS in Biology from Rochester Institute of Technology.

spacer
Carolyn Franceschi
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Pharmaceutical Packaging and Labelling Summit in Zurich; ACG presentation

At next week’s Pharmaceutical Packaging and Labelling Summit in Zurich (18-19 June), Dr. Eugen Hertel from ACG will be speaking on: Challenges for Global Pharma companies to Implement Anti-Counterfeit Strategy for Russian Track & Trace Regulation. This presentation will include details around ‘the fight against counterfeit medicine - there have been and still are worldwide initiatives to make the supply chain and the safety of medicines secure. After large markets such as the USA and Europe passed their laws and regulations for the pharmaceutical manufacturing companies and established the IT infrastructure, Russia is now next on the move.
More info >>

White Papers

Clinical Trial Labelling – More Than Just Labels

Faubel & Co. Nachfolger GmbH

Deciding which label is best for a particular trial project is not always easy. Labels have become multifunctional tools which are able to convey variable data in different languages, indicate first opening, product originality, support ease of use or blind study drugs. They are no longer used as mere carriers of specified contents.
More info >>

 
Industry Events

The Universe of Pre-filled Syringes and Injection Devices

22-23 October 2019, The Swedish Exhibition & Congress Centre Gothia Towers Hotel

PDA’s Universe of Pre-filled Syringes and Injection Devices has become the must-attend meeting for everyone working in the field, and is now the world’s largest conference on this subject
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement